Skip to main content
. 2007 Aug 6;51(10):3531–3536. doi: 10.1128/AAC.00503-07

TABLE 2.

Mechanisms of resistance to β-lactams detected in the bacteremic P. aeruginosa isolates (n = 69)

Strain(s) and resistance mechanism(s)a No. of isolates (no. oprD negative) Modal MICb (μg/ml)
FEP CAZ ATM TIC TZP IPMc
Wild-type reference strain PAO1 1 1 4 16 2 1
Wild-type bacteremic isolates 39 2 1 4 16 4 1
Resistant bacteremic isolates
    XY+ 19 (4) 4 2 4 16 4 8
    AmpC+, XY+ 11 (5) 16 8 16 128 64 16
    OprD 8 (8) 4 2 4 16 4 8
    AmpC+ 7 (2) 8 16 16 64 32 8-64
    PSE-1, XY+ 5 (1) 16 2 8 >256 64 64
    AmpC+, XY+, PSE-1 1 (0) 16 8 16 >256 128
    PSE-1 2 (0) 16 2-4 8-16 >256 128-256
    AmpC+, AB+ 2 (1) 8 4 32 128 16 8
    AB+ 6 (0) 8 4 16 128 16
    AB+, XY+ 4 (0) 8 2 16 128 8
    AmpC+, XY+, TEM-2 1 (0) 16 32 16 >256 64
    OXA-2 1 (0) 2 2 16 128 8
    AmpC+, AB+, XY+ 1 (0) 8 16 16 128 64
    XY+, TEM-2 1 (0) 16 8 8 >256 64
a

Overproduction of MexXY-OprM (XY+) or MexAB-OprM (AB+) pump; production of PSE-1, TEM-2, or OXA-2 β-lactamase; stable overexpression of cephalosporinase AmpC (AmpC+), and deficiency in OprD (OprD).

b

MICs in the intermediate or resistant categories, according to CLSI breakpoints, are in boldface. FEP, cefepime; CAZ, ceftazidime; ATM, aztreonam; TIC, ticarcillin; TZP, tazocillin/piperacillin; IPM, imipenem.

c

MICs of imipenem are only given for OprD isolates.